Lv1
56 积分 2024-03-07 加入
PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model
1个月前
已完结
Investigation of in vivo efficacy of colon targeted nano-drug delivery systems in TNBS-induced colitis rat model for inflammatory bowel disease
1个月前
已关闭
Peripheral immune-inducer dendritic cells drive early-life allergic inflammation
2个月前
已完结
Integrated Single-Cell Profiling Reveals TL1A as a Biomarker and Driver of Type 2 Inflammation via Macrophage-Dependent Immunoregulation in Asthma
2个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
3个月前
已完结
TL1A-activated T cells remodel the rectal mucosa in patients with Crohn’s disease with perianal fistulising disease
3个月前
已完结
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis
4个月前
已完结
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity
5个月前
已完结
Innovative pipeline therapeutics in IBD: anti-TL1A and bispecific antibodies
5个月前
已完结
IBD Matchmaking: Rational Combination Therapy
5个月前
已完结
皖公网安备34019202002308
